Literature DB >> 24183261

Pancreatic cancer: a comprehensive review and update.

Thiruvengadam Muniraj, Priya A Jamidar, Harry R Aslanian.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24183261     DOI： 10.1016/j.disamonth.2013.08.001

Source DB:  PubMed          Journal:  Dis Mon        ISSN： 0011-5029            Impact factor:   3.800


× No keyword cloud information.
  47 in total

1.  Pancreatic Cancer: A Survival Analysis Study in Oklahoma.

Authors:  Margaret Wahutu; Sara K Vesely; Janis Campbell; Anne Pate; Alicia L Salvatore; Amanda E Janitz
Journal:  J Okla State Med Assoc       Date:  2016 Jul-Aug

2.  Targeted Inhibition of Phosphoinositide 3-Kinase/Mammalian Target of Rapamycin Sensitizes Pancreatic Cancer Cells to Doxorubicin without Exacerbating Cardiac Toxicity.

Authors:  David E Durrant; Anindita Das; Samya Dyer; Seyedmehrad Tavallai; Paul Dent; Rakesh C Kukreja
Journal:  Mol Pharmacol       Date:  2015-06-22       Impact factor: 4.436

3.  Hypoxia-inducible factor 1α participates in hypoxia-induced epithelial-mesenchymal transition via response gene to complement 32.

Authors:  Liang Zhu; Qiu Zhao
Journal:  Exp Ther Med       Date:  2017-06-23       Impact factor: 2.447

4.  Comparison of minimal invasive versus open radical antegrade modular pancreatosplenectomy (RAMPS) for pancreatic ductal adenocarcinoma: a single center retrospective study.

Authors:  Hanyu Zhang; Yatong Li; Quan Liao; Cheng Xing; Cheng Ding; Taiping Zhang; Junchao Guo; Xianlin Han; Qiang Xu; Wenming Wu; Yupei Zhao; Menghua Dai
Journal:  Surg Endosc       Date:  2020-10-08       Impact factor: 4.584

5.  Anti-tumor activity of cediranib, a pan-vascular endothelial growth factor receptor inhibitor, in pancreatic ductal adenocarcinoma cells.

Authors:  Majid Momeny; Zivar Alishahi; Haniyeh Eyvani; Fatemeh Esmaeili; Azam Zaghal; Parisa Ghaffari; Javad Tavakkoly-Bazzaz; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Seyed H Ghaffari
Journal:  Cell Oncol (Dordr)       Date:  2019-09-06       Impact factor: 6.730

Review 6.  Combination Therapies and Drug Delivery Platforms in Combating Pancreatic Cancer.

Authors:  Fan Lei; Xinyuan Xi; Surinder K Batra; Tatiana K Bronich
Journal:  J Pharmacol Exp Ther       Date:  2019-02-22       Impact factor: 4.030

Review 7.  Novel strategies for managing pancreatic cancer.

Authors:  Welley S Loc; Jill P Smith; Gail Matters; Mark Kester; James H Adair
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

8.  Chemotherapy Use, End-of-Life Care, and Costs of Care Among Patients Diagnosed With Stage IV Pancreatic Cancer.

Authors:  Yuhua Bao; Renee C Maciejewski; Melissa M Garrido; Manish A Shah; Paul K Maciejewski; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2017-12-11       Impact factor: 3.612

9.  HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancer.

Authors:  Alan S Wang; Alessia Lodi; Lee B Rivera; Jose L Izquierdo-Garcia; Matthew A Firpo; Sean J Mulvihill; Margaret A Tempero; Gabriele Bergers; Sabrina M Ronen
Journal:  NMR Biomed       Date:  2014-09-09       Impact factor: 4.044

Review 10.  Antecolic versus retrocolic reconstruction after partial pancreaticoduodenectomy.

Authors:  Felix J Hüttner; Rosa Klotz; Alexis Ulrich; Markus W Büchler; Markus K Diener
Journal:  Cochrane Database Syst Rev       Date:  2016-09-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.